InvestorsHub Logo

aesop1

05/30/23 2:59 PM

#597052 RE: W_W #597051

There is a difference between establishing internal manufacturing versus setting a cdmo up owned by the ceo's fund. Big difference.

vator

05/30/23 3:03 PM

#597053 RE: W_W #597051

That’s all well and good and a fair explanation. NWBO paid for most of it minus the personal but paid them 15% above their personnel cost. Why in eff did we need to have Toucan? Only brings more control and money to Linda. Sure as hell didn’t help us that much.

dennisdave

05/30/23 3:06 PM

#597054 RE: W_W #597051

no you really didnt explain anything with your Tesla example. Telsa is an eCAR manufacturer NWBO IS NOT a CDMO Do you understand the difference?

You stick with your opinion that CRL the go-to manufacturer for nonrevenue biotech with 21,400 employees 150 locations and $4 billion in revue is a loser and therefore its better to start your own CDMO from scratch, fine with me.

According to you, all biotech managers dont understand how to build a biotech except the brilliant LP. Heck, you have to justify something for the dilution that shareholders have been through in order to pay for Linda's private CDMO.